comparemela.com

Red blood cell transfusion to treat anemia of dialysis is more common with persistent hyporesponse to erythropoiesis-stimulating agents (ESA).

Related Keywords

New York ,United States ,Texas ,Christine Ferro ,Milliman Inc ,National Kidney Foundation ,Clinical Meetings ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.